Qin Meng

1 article listing Qin Meng in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial Nature Communications